Global clinical trial landscape
PROTAC and molecular glue degrader trials across oncology and inflammation: all sponsors, phases, and enrollment status
Phase 2 and 3 atopic dermatitis and asthma trials, including biologics, JAK inhibitors, and novel oral agents targeting STAT6 and related pathways
IRAK4, STAT6, IRF5, and SLE trial landscape: oral small molecules and degraders in rheumatology and dermatology
All sponsors, phases, and enrollment status for GLP-1 agonist trials across obesity and diabetes
Phase 2 and Phase 3 Alzheimer's disease and MCI trials with amyloid, tau, and lifestyle arms
PD-1/PD-L1 checkpoint inhibitor trials, CAR-T, and combination arms across tumor types
Orphan-designated trials actively enrolling: rare metabolic, neurological, and genetic conditions